estriol has been researched along with Epistaxis in 5 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Epistaxis: Bleeding from the nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combined treatment regimen with APC and topically applied estriol provides a new treatment concept of epistaxis in HHT." | 7.72 | [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa]. ( Bergler, WF; Hörmann, K; Oulmi, J; Riedel, F; Sadick, H, 2003) |
| "Application of topical estriol ointment is an effective treatment for hereditary hemorrhagic telangiectasia (HHT) epistaxis." | 5.22 | Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia. ( Haji, T; Minami, K, 2016) |
| "The study goal was to report on the long-term results and effect of argon plasma coagulation (APC) surgery and topical estriol in patients with Osler's disease who had recurrent epistaxis." | 5.10 | Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler's disease. ( Bergler, W; Hörmann, K; Karl, H; Naim, R; Oulmi, J; Ramin, N; Sadick, H, 2003) |
| " In a few small studies, thalidomide was shown to consistently improve severity and frequency of epistaxis and improve hemoglobin concentrations while decreasing the need for transfusion." | 4.98 | Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review. ( Clark, C; Halderman, AA; Invernizzi, R; Marple, BF; Poetker, DM; Reh, DD; Ryan, MW; Sindwani, R, 2018) |
| "The combined treatment regimen with APC and topically applied estriol provides a new treatment concept of epistaxis in HHT." | 3.72 | [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa]. ( Bergler, WF; Hörmann, K; Oulmi, J; Riedel, F; Sadick, H, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halderman, AA | 1 |
| Ryan, MW | 1 |
| Clark, C | 1 |
| Sindwani, R | 1 |
| Reh, DD | 1 |
| Poetker, DM | 1 |
| Invernizzi, R | 1 |
| Marple, BF | 1 |
| Minami, K | 1 |
| Haji, T | 1 |
| Sadick, H | 3 |
| Riedel, F | 2 |
| Oulmi, J | 2 |
| Hörmann, K | 3 |
| Bergler, WF | 1 |
| Naim, R | 1 |
| Ramin, N | 1 |
| Karl, H | 1 |
| Bergler, W | 2 |
| Gotte, K | 1 |
1 review available for estriol and Epistaxis
| Article | Year |
|---|---|
Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
Topics: Administration, Oral; Administration, Topical; Angiogenesis Inhibitors; Epistaxis; Estriol; Estrogen | 2018 |
3 trials available for estriol and Epistaxis
| Article | Year |
|---|---|
Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Topics: Administration, Intranasal; Epistaxis; Estriol; Estrogens; Female; Genetic Diseases, Inborn; Humans; | 2016 |
Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Combined Modality Therapy; Epistaxis; Estriol; Fe | 2003 |
Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Argon; Chemotherapy, Adjuvant; Child; Drug Moni | 2002 |
1 other study available for estriol and Epistaxis
| Article | Year |
|---|---|
[Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Child; Combined Modality Therap | 2003 |